New aspects of gene-silencing for the treatment of cardiovascular diseases

about

Nanocarriers as treatment modalities for hypertension.Nucleic Acid Delivery for Endothelial Dysfunction in Cardiovascular Diseases New insights into the non-hemostatic role of von Willebrand factor in endothelial protection.

P2860

Q38760963-0A87B2A4-F4ED-4E5D-95E2-A1FA65E2EAAA Q39003359-EFC0C1AD-3A16-497C-9A9D-B43E1A9A30E7 Q48719553-EBEAA3ED-352B-486B-936F-4C928C7F0B40

P2860

New aspects of gene-silencing for the treatment of cardiovascular diseases

Item

http://www.wikidata.org/entity/Q37277425

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New aspects of gene-silencing for the treatment of cardiovascular diseases

@en

New aspects of gene-silencing for the treatment of cardiovascular diseases.

@nl

type

Item

label

New aspects of gene-silencing for the treatment of cardiovascular diseases

@en

New aspects of gene-silencing for the treatment of cardiovascular diseases.

@nl

prefLabel

New aspects of gene-silencing for the treatment of cardiovascular diseases

@en

New aspects of gene-silencing for the treatment of cardiovascular diseases.

@nl

P1476

New aspects of gene-silencing for the treatment of cardiovascular diseases

@en

P2093

Almuth Zech

http://www.w3.org/2001/XMLSchema#string

Andrea Nolte

http://www.w3.org/2001/XMLSchema#string

Bernd Neumann

http://www.w3.org/2001/XMLSchema#string

Christian Schlensak

http://www.w3.org/2001/XMLSchema#string

Hans-Peter Wendel

http://www.w3.org/2001/XMLSchema#string

Nadja Perle

http://www.w3.org/2001/XMLSchema#string

Olivia Koenig

http://www.w3.org/2001/XMLSchema#string

Tobias Walker

http://www.w3.org/2001/XMLSchema#string

P2860

A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo

Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes

The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

The promises and pitfalls of RNA-interference-based therapeutics

Improvements in siRNA properties mediated by 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA)

Atherosclerosis — An Inflammatory Disease

Antisense oligonucleotides for the treatment of dyslipidaemia

Role for a bidentate ribonuclease in the initiation step of RNA interference

P304

881-914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/PH6070881

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258922768

http://www.w3.org/2001/XMLSchema#string

P698

24276320

http://www.w3.org/2001/XMLSchema#string

P921

gene silencing

cardiovascular disease

P932

3816708

http://www.w3.org/2001/XMLSchema#string

New aspects of gene-silencing for the treatment of cardiovascular diseases

about

P2860

P2860

New aspects of gene-silencing for the treatment of cardiovascular diseases

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932